The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs and weak US business. He suggests Sun Pharma and Cipla as resilient options ...

California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...

As prescription drug prices continue to spiral and federal efforts to control them stall, state lawmakers are focusing on ...

The Food and Drug Administration (FDA) has ordered the recall of several batches of a brand of antibiotics used to treat ...

For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.

Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...

Lawmakers in Michigan have introduced a package of bills designed to lower costs and expand healthcare access. Senate Bill 3 ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.